RETHINK
Chemotherapy
Our mission is to protect patients from unnecessary chemo.
Today, there is no way to determine who is cured of their cancer by their surgery.
As a result, 70% of patients are placed on chemo when they don’t need to be.
Spark Molecular is focusing on giving patients clarity about their need for chemotherapy after surgery.
